Elsevier

Tetrahedron

Volume 74, Issue 34, 23 August 2018, Pages 4521-4529
Tetrahedron

Total synthesis and cytotoxic activity of dechlorogreensporones A and D

https://doi.org/10.1016/j.tet.2018.07.025Get rights and content

Abstract

The first and convergent total syntheses of polyketide natural products dechlorogreensporones A and D have been accomplished in 17 longest linear steps with 2.8% and 5.4% overall yields, respectively, starting from known methyl 2-(2-formyl-3,5-dihydroxyphenyl)acetate and commercially available R-(+)-propylene oxide and 1,2-epoxy-5-hexene. Our synthesis exploited key Mitsunobu esterification and (E)-selective ring-closing metathesis (RCM) to assemble the macrocycles as well as a Jacobsen hydrolytic kinetic resolution to install the stereogenic centers. Both synthetic compounds were found to display significant cytotoxic activity against seven human cancer cell lines with the IC50 ranges of 6.66–17.25 μM.

Introduction

The well-known 14-membered β-resorcylic acid lactones (RALs) are a group of fungal polyketide metabolites that possess a multitude of biological and pharmacological activities [1]. A subclass of RALs are those containing an α,β-unsaturated ketone at the 8–10 positions, which are derivatives of radicicol [2]. The major examples of this subclass of RALs are the pochonins [3] and the monocillins [4] (Fig. 1). This group of metabolites has been shown to exhibit various interesting biological activities e.g. antiviral activity against Herpes Simplex Virus 1 (HSV 1) [3a], antifungal activity (against Mucorflavas IFO 9560) [5], HSP-90 inhibitory activity [6], and latent HIV-1 reactivation activity [3c]. In consequence of their diverse and promising biological properties and structural features, this class of macrolides has been synthetic targets for many synthetic organic research groups worldwide [7]. Precedented strategies to construct the macrocyclic cores of RALs possessing similar core skeleton mainly relied on esterification reaction [7] and ring-closing metathesis [7](c), [7](f), [7](g), [7](h), [7](i), [7](j), [7](k) (Fig. 2). Other key bond formations included Pd-catalyzed cross coupling/elimination [7](a), [7](b), [7](d), [7](e), substitution by dithiane anion [7c] and nucleophilic addition to Weinreb amide (acylation) [[7](f), [7](g), [7](h), [7](i)].

Dechlorogreensporones A (5) and D (6) are new 14-membered β-RALs, which were isolated, along with other 12 new RALs from a culture of a freshwater fungus Halenospora sp. by Oberlies and co-workers in 2014 (Fig. 3) [8]. Compounds 5 and 6 are radicicol analogues possessing a methoxy group at the 16-position, which represent rare examples of RALs containing β-resorcylic acid monomethyl ethers. Dechlorogreensporones A and D have the same planar structure which includes a stereogenic center at the 2-position. However, the minor structural difference is that 5 contains a keto group at the 5-position, whereas 6 bears an alcohol stereogenic center. In addition, dechlorogreensporone A (5) is structurally very similar to the previously reported natural product cryptosporiopsin A [9]. The absolute configuration of the C-2 asymmetric carbon in macrolactones 5 and 6 and other co-metabolites was proposed by the isolation group to be S by the evidence of X-ray diffraction analysis of the bromobenzoyl derivative of one of the metabolites in the series. The absolute configuration of the C-5 in 6 and co-metabolites containing C-5 alcohol stereogenic center was assigned to be S via a Mosher's ester method. Interestingly, the assigned C-2 absolute configuration of 5 and 6 and other analogues in the series is opposite to that of cryptosporiopsin A, which was assigned by analogy to the known RAL pochonin D. Dechlorogreensporones A and D were tested for cytotoxic activities against two human cancer cell lines and were found to exhibit cytotoxicity against the MDA-MB-435 (melanoma) cancer cell line with IC50 values of 14.1 and 11.2 μM, respectively. They also exhibited cytotoxicity against the HT-29 (colon) cancer cell line with IC50 values of >20 and 25.4 μM, respectively. Due to promising biological activities of this subclass of RALs and our ongoing program for anticancer drug discovery, our research group has been focusing on a synthetic program of selected compounds of this class. Herein, we report the first total synthesis of both 5 and 6 as well as evaluation of their cytotoxic activity against seven human cancer cell lines.

Section snippets

Results and discussion

Our retrosynthetic approach toward dechlorogreensporones A (5) and D (6) would utilize similar disconnection strategy to Mohapatra and Thirupathi's [7j] and our previous report [7k] via ring-closing metathesis (RCM) as a key macrocyclization protocol and to concomitantly establish the (E) geometry of C8–C9 olefin. We would also rely on the Mitsunobu esterification to construct the ester functional group of the diene RCM precursor (Scheme 1). Although the targets 5 and 6 only differ by the

Conclusion

In conclusion, the first and convergent total syntheses of dechlorogreensporones A (5) and D (6) have been accomplished via a longest linear sequence of 17 steps in 2.8% and 5.4% overall yields, respectively, from known phenol 14 and commercially available R-(+)-propylene oxide and 1,2-epoxy-5-hexene. Our approach exploited key Mitsunobu esterification and ring-closing metathesis to assemble the macrocycles and construct the (E)-olefin. Jacobsen hydrolytic kinetic resolution was also utilized

General

All reactions were performed under argon or nitrogen atmosphere in oven- or flamed-dried glassware unless otherwise noted. Solvents were used as received from suppliers or distilled prior to use using standard procedures. All other reagents were obtained from commercial sources and used without further purification. Column chromatography was performed on SiliaFlash® G60 Silica (60–200 μm, Silicycle) or Silica gel 60 (0.063–0.200 mm, Merck). Thin-layer chromatography (TLC) was performed on

Acknowledgements

This work was financially supported by the Thailand Research Fund (Grant No. TRG5880272). We also acknowledge partial support from the Center of Excellence for Innovation in Chemistry (PERCH-CIC), Office of the Higher Education Commission, Ministry of Education (OHEC). Additional support is generously provided by the Graduate School, Prince of Songkla University and the Development and Promotion of Science and Technology Talents Project (DPST) for L. Jeanmard. Ms.Aticha Thiraporn, Mr.Pongsit

References (18)

  • P. Delmotte et al.

    Nature

    (1953)
  • T. El-Eliman et al.

    J. Nat. Prod.

    (2014)
  • M. von Delius et al.

    J. Am. Chem. Soc.

    (2012)
  • J. Cai et al.

    Bioorg. Med. Chem.

    (2015)
  • X.D. Wang et al.

    Tetrahedron

    (2016)
  • M.D. Morin et al.

    Org. Lett.

    (2005)
  • N. Winssinger et al.

    Chem. Commun.

    (2007)
    S. Barluenga et al.

    Chimie

    (2008)
  • V. Hellwig et al.

    J. Nat. Prod.

    (2003)
    H. Shinonaga et al.

    Tetrahedron

    (2009)
    E.J. Mejia et al.

    J. Nat. Prod.

    (2014)
  • W.A. Ayer et al.

    Can. J. Microbiol.

    (1980)
There are more references available in the full text version of this article.

Cited by (5)

  • The chemistry of the carbon-transition metal double and triple bond: Annual survey covering the year 2018

    2019, Coordination Chemistry Reviews
    Citation Excerpt :

    A related double interligand RCM was employed for the synthesis of encapsulated platinum bis(selenide) complexes (e.g. 289) [702]. Numerous macrocyclic compounds (rings with ≥11 atoms) were synthesized using the RCM reaction in 2018 (Fig. 14), including: (1) a cyclotetradecene derivative (e.g. 292) for the preparation of oxyfunctionalized cembranoids [703]; (2) macrocyclic diamines (e.g. 293) and a study of the effect of ring size, E/Z geometry, and catalyst on kinetic and thermodynamic ring closure using α,m,ω-unsaturated triene substrates [704]; (3) a macrocyclic amine-bridged 1,4-cyclohexadiene (e.g. 294) for the preparation of the haliclonin A skeleton [705]; (4) the macrocyclic amine cage-type structure (e.g. 295) for preparation of the tetracyclic framework of sarain A [706]; (5) a macrocyclic ketone (e.g. 296) for total synthesis of asperchalasines A–E [707]; (6) a furan-bridged macrocyclic ketone (e.g. 297) for total synthesis of boscartin F [708]; (7) macrocyclic lactones, including those employed for total synthesis and structural revision of iriomoteolide-2a (e.g. 298) [709], iriomoteolide-3a (e.g. 299, an earlier step employs cross metathesis using a hexa-1,5-dien-3,4-ol derivative) [710], ripostatin analogs [711], tiacumicin A [712], the proposed structure of pandangolide 1 [713], dechlorogreensporones A and D (e.g. 300) [714], 5′-hydroxyzearalenone [715], pestalotioprolide C [716], musk scent macrocyclic lactones [717], paecilomycin E and F and related compounds [718], β-zearalenol [719], and patulolide A [720]; (8) the macrocyclic tris(oxazole)-lactone ring system of mycalolides (e.g. 301, the reaction was very highly E-selective if zinc salts added due to a templation effect) [721]; (9) a macrocyclic hexakis(lactone) system (cyclic butylene terephthalate trimer) [722]; (10) preparation of macrocyclic lactones through selective alkene isomerization followed by RCM in a system containing a metathesis catalyst and a ruthenium alkene isomerization catalyst [723]; (10) a macrocyclic polyene-lactone (e.g. 302) for the total synthesis of mangrolide A [724]; (11) macrocyclic tetrahydrofuran-bridged lactones for the preparation of hybrid natural products analogs [725]; (12) a macrocyclic lactone-lactam (e.g. 303) employed in the preparation of laingolide B stereoisomers [726]; (13) macrocyclic tris(lactam)s (e.g. 304) for the preparation of the solomonamide macrocyclic core [727]; (14) a macrocyclic lactone-bis(lactam) spanning a quinoline ring system for the preparation of a cyclophilin inhibitor [728]; (15) macrocycle-bridged or stapled peptides [729–744]; (16) stapling of a pyridine–acetylene–phenol oligomer templated by a saccharide derivative [745]; (17) failure to form a meta cyclophane system by RCM [746] and the m-furanophane ring system of furanocembranoid 1 [747]; (18) m-furanophane ring systems as substrates for transannular [4+3] cycloaddition [748]; (19) a macrocycle-bridged NHC ligand (e.g. 305) and demonstration of a one-pot acrylate-alkene CM Cu-catalyzed hydroboration using the macrocyclic NHC ligand [749]; (20) a macrocycle-bridged oxazole for the macrocyclic core of salarin C [750]; (21) a macrocycle-bridged bithienyl system [751]; (22) anion-responsive macrocycle-bridged dipyrrolyldiketone-BF2 complexes [752]; (23) an inverted spirocyclic architecture [753]; (24) rotaxanes [754]; (25) a copper-bridged pseudorotaxane [755]; (26) a six-fold molecular granny knot [756]; (27) a composite knot with nine crossings [757]; (28) a molecular trefoil knot system [758]; (29) calix[6]arene-based [2]catenanes [759]; (30) a quasi[1]catenane system [760]; (31) an encapsulated diketopyrrolopyrrole systems as precursors to low band-gap polymers [761]; and (32) silicon-tethered cyclic polystyrene systems [762]. Macrocyclic lactones were successfully prepared at high concentration using a technique where the ADMET polymers were depolymerized and the macrocycles then removed from the system at high vacuum using a derivative of catalyst 4 embedded in a metal organic framework [763].

View full text